On Behalf Of The Improve Study Group

The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study

A. Smit, B. Gigante, F. Veglia, 2021, Biomedicines.

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study

A. Smit, A. Silveira, B. Gigante, 2021, Biomedicines.